| Fiscal period | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|
| Period End Date | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 |
|---|
| Sales | 12,647.00 | 12,401.02 | 10,119.14 | 9,985.80 | 13,202.00 | 12,461.54 | 11,571.67 | 10,629.72 | 10,371.39 | 9,560.65 |
| Total Revenues | 12,647.00 | 12,401.02 | 10,119.14 | 9,985.80 | 13,202.00 | 12,461.54 | 11,571.67 | 10,629.72 | 10,371.39 | 9,560.65 |
| Cost of sales | 8,816.00 | 8,728.77 | 7,304.80 | 6,894.92 | 9,606.91 | 9,062.44 | 8,337.70 | 7,617.46 | 7,460.08 | 6,904.63 |
| Gross Profit | 3,831.00 | 3,672.25 | 2,814.34 | 3,090.89 | 3,595.08 | 3,399.10 | 3,233.97 | 3,012.26 | 2,911.32 | 2,656.01 |
| Depreciation and amortization | 182.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Selling, general and administrative | 2,771.00 | 2,812.66 | 2,246.95 | 2,357.92 | 2,701.88 | 2,539.73 | 2,416.50 | 2,243.36 | 2,196.17 | 1,978.96 |
| Restructuring Costs | 131.00 | 7.94 | 32.09 | 14.71 | 62.91 | -- | 45.89 | 34.93 | 0.00 | 0.00 |
| Merger and integration costs | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Transaction costs related to Animal Health spin-off | -- | -- | -- | -- | 38.76 | -- | -- | -- | -- | -- |
| Litigation settlements | -- | -- | -- | 0.00 | (38.49) | -- | -- | -- | -- | -- |
| Operating income | 747.00 | 851.66 | 535.30 | 718.26 | 753.05 | 859.37 | 771.57 | 733.97 | 715.14 | 677.05 |
| Interest expense | 44.00 | 27.60 | 41.38 | 50.79 | 78.79 | 53.65 | 31.89 | 26.01 | 24.06 | 27.54 |
| Interest income | 17.00 | 6.45 | 9.84 | 15.76 | 21.24 | 17.55 | 13.28 | 12.94 | 13.66 | 12.85 |
| Other, net | 1.00 | 0.04 | (3.87) | (2.92) | (0.15) | (0.42) | 2.88 | (0.14) | 4.57 | 2.33 |
| Pre-Tax Income - Domestic | 506.00 | 593.14 | 430.84 | 507.00 | 505.88 | 649.66 | 625.79 | 591.32 | 543.43 | 517.95 |
| Pre-Tax Income - Foreign | 215.00 | 237.41 | 69.06 | 173.30 | 189.47 | 173.19 | 130.04 | 129.44 | 165.88 | 146.74 |
| Income from continuing operations before taxes, minority interest and equity in earnings of affiliates | 721.00 | 830.55 | 499.90 | 680.31 | 695.35 | 822.85 | 755.84 | 720.76 | 709.31 | 664.69 |
| Income taxes | 170.00 | 197.35 | 95.37 | 159.52 | 155.49 | 362.51 | 217.96 | 211.39 | 215.61 | 190.89 |
| Current tax expense:Foreign | 44.00 | 42.75 | 40.80 | 42.00 | 68.30 | 50.08 | 41.36 | 25.10 | 31.04 | 35.88 |
| Deferred tax expense (benefit):Foreign | (12.00) | 3.70 | (30.06) | (11.29) | (27.26) | (14.06) | (14.17) | (3.85) | 3.98 | 3.97 |
| Current tax expense:State and local | 49.00 | 37.26 | 24.64 | 28.15 | 35.20 | 28.52 | 28.23 | 29.58 | 27.99 | 27.27 |
| Deferred tax expense (benefit):U.S. Federal | (48.00) | (12.12) | (18.03) | 5.63 | (9.33) | 13.69 | (18.09) | (3.38) | 2.68 | 10.33 |
| Current tax expense:U.S. federal | 150.00 | 128.33 | 82.91 | 93.42 | 93.21 | 283.42 | 185.44 | 162.95 | 151.89 | 139.25 |
| Deferred tax expense (benefit):State and local | (13.00) | (2.57) | (4.89) | 1.60 | (4.63) | 0.86 | (4.81) | 0.99 | (1.96) | (4.53) |
| Minority Interest in Net Income of Subsidiaries | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Equity in earnings of affiliates | 15.00 | 20.01 | 12.34 | 17.90 | 22.27 | 16.59 | 18.52 | 14.06 | 11.73 | 10.19 |
| Loss on sale of equity investment | -- | 7.32 | 1.57 | 186.77 | -- | (17.64) | -- | -- | -- | (12.54) |
| Income from Continuing Operations | 566.00 | 660.53 | 418.44 | 725.46 | -- | -- | -- | -- | -- | -- |
| Discontinued operations: Income tax benefit | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Discontinued operations: Loss from operations of discontinued components | -- | 0.00 | 0.99 | (6.32) | -- | -- | -- | -- | -- | -- |
| Consolidated Net Income (Loss) | 566.00 | 660.53 | 419.42 | 719.14 | 562.13 | 459.29 | 556.40 | 523.43 | 505.44 | 471.46 |
| Less: Net income attributable to noncontrolling interests | 28.00 | 29.29 | 15.63 | 24.77 | 26.25 | 52.99 | 49.62 | 44.37 | 39.36 | 39.91 |
| Net income (loss) attributable to noncontrolling interests from discontinued operations | -- | -- | 0.00 | (0.37) | -- | -- | -- | -- | -- | -- |
| Net income attributable to Henry Schein, Inc | 538.00 | 631.23 | 403.79 | 694.73 | 535.88 | 406.30 | 506.78 | 479.06 | 466.08 | 431.55 |
| Earnings from continuing operations per share: Basic | 3.95 | 4.51 | 2.83 | 4.74 | -- | -- | -- | -- | -- | -- |
| Earnings (loss)from discontinued operations per share: Basic | 0.00 | 0.00 | 0.01 | (0.04) | -- | -- | -- | -- | -- | -- |
| Earnings per share: Basic | 3.95 | 4.51 | 2.83 | 4.70 | 3.51 | 2.59 | 3.14 | 2.89 | 2.77 | 2.51 |
| Earnings from continuing operations per share: Diluted | 3.91 | 4.45 | 2.81 | 4.69 | -- | -- | -- | -- | -- | -- |
| Earnings (loss)from discontinued operations per share: Diluted | 0.00 | -- | 0.01 | (0.04) | -- | -- | -- | -- | -- | -- |
| Earnings per share: Diluted | 3.91 | 4.45 | 2.82 | 4.65 | 3.49 | 2.57 | 3.10 | 2.85 | 2.72 | 2.47 |
| Weighted-average common shares outstanding: Basic | 136.06 | 140.09 | 142.50 | 147.82 | 152.66 | 156.79 | 161.64 | 165.69 | 168.53 | 171.85 |
| Weighted-average common shares outstanding: Diluted | 137.76 | 141.77 | 143.40 | 149.26 | 153.71 | 158.21 | 163.72 | 168.25 | 171.48 | 175.24 |